Impact of pharmacokinetics to reduce bleeding in a cohort of patients with severe hemophilia A in a personalized comprehensive management program
Introduction: In recent decades, hemophilia A treatment has been focused on body weight, without taking pharmacokinetic parameters into account. Previous research has shown that the individual pharmacokinetic response is more effective in predicting the required dose of clotting factor. We want to...
Guardado en:
Autores principales: | Samuel sarmiento Doncel, Gina Alejandra Diaz Mosquera, Javier Mauricio Cortes, Nelson Ramirez, Francisco Javier Meza, Carol Agudelo Rico |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
PAGEPress Publications
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a5ae7a1c44ac4daba6f5389cbcdbe17d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
COMPARISON OF INDIVIDUAL PHARMACOKINETIC DOSING TOOLS IN PATIENTS WITH HEMOPHILIA A
por: Can Alp GENÇ, et al.
Publicado: (2021) -
External qualification of the Web‐Accessible Population Pharmacokinetic Service–Hemophilia (WAPPS‐Hemo) models for octocog alfa using real patient data
por: Pierre Chelle, et al.
Publicado: (2021) -
All bleeding matters … but the details may not
por: Sarah H. O’Brien
Publicado: (2020) -
BLEEDING MANAGEMENT DURING DELIVERY AND POSTPARTUM PERIOD IN GLANZMANN THROMBASTHENIA: EXPERIENCES FROM TWO CASES
por: Özden ÖZLÜK, et al.
Publicado: (2021) -
Derivation of a Pharmacokinetic Model to Include a Plasma-Derived, von Willebrand Factor-Containing Factor VIII (Koate-DVI) Concentrate and its Low-Dose Use
por: Dagmar M. Hajducek, et al.
Publicado: (2021)